Budesonide Dosing and Treatment for Colitis

Dosing Recommendations

Budesonide MMX is particularly effective for left-sided disease but less effective for extensive colitis 1
After 8 weeks, treatment should not be extended if inadequate response is observed 1
For microscopic colitis (including collagenous and lymphocytic colitis), the standard induction dose is also 9 mg daily for 8 weeks 2
After achieving remission, budesonide should be tapered over 1-2 weeks rather than abruptly discontinued 2

Evaluate patients for symptomatic response to budesonide between 4-8 weeks to determine need for therapy modification 1, 2
For moderate ulcerative colitis, response should be assessed within the first 2 weeks to determine if therapy modification is needed 3
If there is inadequate response after 2 weeks, consider escalating to advanced therapies 3

Budesonide should not be used for long-term maintenance therapy in ulcerative colitis as corticosteroids are ineffective for this indication 1, 4
For patients with microscopic colitis who experience symptom recurrence, maintenance therapy with budesonide may be considered 2
Maintenance dosing typically starts at 6 mg daily but should be tapered to the lowest effective dose 2

For moderate to severe ulcerative colitis, oral prednisolone 40 mg daily with tapering over 6-8 weeks is recommended 3, 5
For mild to moderate ulcerative colitis, 5-ASA therapy (2-3 g/day) is recommended as first-line therapy before considering corticosteroids 5
If 5-ASA therapy fails, oral prednisolone or budesonide MMX can be considered 5
For patients requiring two or more courses of corticosteroids in the past year or who become corticosteroid-dependent, consider treatment escalation with thiopurines, anti-TNF therapy, vedolizumab, or tofacitinib 5